Low prevalence of lipid lowering drug use in older men with established coronary heart disease

Heart

Volumn 88, Issue 1, 2002, Pages 25-29

  Whincup, P H ^a   Emberson, J R ^b   Lennon, L ^b   Walker, M ^b   Papacosta, O ^b   Thomson, A ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG INDICATION; GENERAL PRACTICE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036082296     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.1.25     Document Type: Article

References (29)

1. Randomized controlled trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia
5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TEXCAPS
6. Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment
7. Gemfibrizol for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
8. Joint British recommendations on prevention of caronary heart disease in clinical practice
9. Secondary prevention in coronary heart disease: Baseline survey of provision in general practice
10. Use of statins in general practices, 1996-8: Cross-sectional study
11. Lipid concentrations and the use of lipid lowering drugs: Evidence from a national cross sectional survey
12. British regional heart study: Cardiovascular risk factors in middle-aged men in 24 towns
13. Twenty year follow-up of a cohort based in general practices in 24 British towns
14. The Dinamap 1846SX oscillometric blood pressure recorder: Comparison with the Hawksley random zero sphygmomanometer under field study conditions
15. An updated coronary risk profile: A statement for health professionals
16. Validation of patient recall of doctor-diagnosed heart attack and stroke: A postal questionnaire and record review comparison
17. Sex inequalities in ischaemic heart disease in general practice: Cross-sectional survey
18. Aspirin use in middle-aged men with cardiovascular disease: Are opportunities being missed?
19. Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe: Findings from EUROASPIRE study
20. Might treatment of hypercholesterolaemia increase non-cardiac mortality?
21. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
22. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: An updated Sheffield table
23. Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population
24. Treating dyslipidaemia in primary care
25. Statin therapy: What now?